InsidersTradesSigma
Follow the PYC THERAPEUTICS LIMITED share price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares trade on the AU market, under the supervision of ASX. Market capitalisation: €2.2bn. The latest transaction was filed on 14 August 2026 (Purchase). Among the most active insiders: Dr Rohan Hockings. All data is free.
Analysts rate PYC THERAPEUTICS LIMITED Strong Buy (bullish), based on 5 analysts. Average price target: A$3.75.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
PYC THERAPEUTICS LIMITED is a company listed on the Australian Securities Exchange, specializing in the development of innovative therapies. It focuses on treatments for serious diseases using advanced technologies.